Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
Switzerland
Zile Bonbons AG is a Swiss specialist contract manufacturer of lozenges, chews, and dragees for the pharmaceutical (OTC), nutraceutical, dietary supplement, and confectionery industries. Headquartered in Rupperswil, Switzerland, they have a dedicated OTC lozenges manufacturing plant. They provide full-service contract development and manufacturing from product conception through commercial production, including formulation development, prototyping, sourcing, manufacture, packaging, and logistics. Their technologies include stamping, cutting, moulding, and coating, with primary packaging options (wrapper/flow pack, bags, flip-top boxes, bars, blisters). They manufacture alternative drug delivery systems as centre-filled OTC lozenges with precise API dosage. They have pharmaceutical GMP expertise and are FDA-registered (FEI 3003236010) with 1 FDA inspection (VAI). Classified as CMO rather than CDMO because their development work is focused on lozenge formulation for third parties, but they do not position themselves as offering full drug development services beyond the lozenge/chew format.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
Finland
3P Biovian is a global biologics CDMO providing end-to-end services from early-stage development to commercialization. They specialize in proteins, viral vectors, plasmid DNA, and cell therapy products with cGMP manufacturing facilities in Turku, Finland, and Pamplona-Noain, Spain. The company has invested over 50 million euros in facility expansion.